Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc I Chimowitz

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
JAMA Neurology|December 1, 2015
Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) TrialHyung-Min Kwon, Michael J Lynn, Tanya N Turan, et al.
Stroke|January 17, 2015
Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysisHelmi L Lutsep, Stanley L Barnwell, Darren T Larsen, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 12, 2014
Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosisElena López-Cancio, Maria Gisele Matheus, Jose G Romano, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 25, 2017
Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis TrialTanya N Turan, Sami Al Kasab, Azhar Nizam, et al.
Stroke|September 19, 2015
Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?Helmi L Lutsep, Michael J Lynn, George A Cotsonis, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 15, 2019
Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis TrialTanya N Turan, Sami Al Kasab, Alison Smock, et al.
The Neurologist|December 27, 2018
Type and Duration of Exercise in the SAMMPRIS TrialTanya N Turan, Sami Al Kasab, Azhar Nizam, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 8, 2016
Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis?Tanya N Turan, Alison Smock, George Cotsonis, et al.
Journal of Neurointerventional Surgery|September 15, 2012
Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trialColin P Derdeyn, David Fiorella, Michael J Lynn, et al.
Stroke|December 7, 2002
Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and womenHarland Austin, Marc I Chimowitz, Holly A Hill, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
JAMA Neurology|December 1, 2015
Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) TrialHyung-Min Kwon, Michael J Lynn, Tanya N Turan, et al.
Stroke|January 17, 2015
Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysisHelmi L Lutsep, Stanley L Barnwell, Darren T Larsen, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 12, 2014
Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosisElena López-Cancio, Maria Gisele Matheus, Jose G Romano, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 25, 2017
Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis TrialTanya N Turan, Sami Al Kasab, Azhar Nizam, et al.
Stroke|September 19, 2015
Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?Helmi L Lutsep, Michael J Lynn, George A Cotsonis, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 15, 2019
Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis TrialTanya N Turan, Sami Al Kasab, Alison Smock, et al.
The Neurologist|December 27, 2018
Type and Duration of Exercise in the SAMMPRIS TrialTanya N Turan, Sami Al Kasab, Azhar Nizam, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 8, 2016
Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis?Tanya N Turan, Alison Smock, George Cotsonis, et al.
Journal of Neurointerventional Surgery|September 15, 2012
Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trialColin P Derdeyn, David Fiorella, Michael J Lynn, et al.
Stroke|December 7, 2002
Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and womenHarland Austin, Marc I Chimowitz, Holly A Hill, et al.
Pageof 7